FIELD: medicine; ophthalmology.
SUBSTANCE: group of inventions is intended for treating ophthalmic diseases. An agent for treating ophthalmic diseases is a combination of taurine and cytochrome C. In another embodiment, a pharmaceutical composition comprising said agent in a therapeutically effective amount and a pharmaceutically acceptable carrier are provided.
EFFECT: using the group of inventions enables to obtain the required therapeutic effect with smaller amounts of active substances as compared to commercially available mono-preparations.
6 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DISULFIRAM AND TAURINE-CONTAINING OPHTHALMOLOGICAL MEDICATION IN FORM OF EYE DROPS | 2012 |
|
RU2485939C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING EYE DISEASES RELATED TO EYE TISSUE METABOLIC DISEASE AND INFLAMMATORY EYE TISSUE INJURY | 2013 |
|
RU2521337C1 |
| EYE DROPS BASED ON COMPOSITION OF PHARMACEUTICALLY ACCEPTABLE ADDITIVE ACID SALTS AND METHYLETHYL PYRIDONOL AND TAURINE CONTAINING COMPOSITION OF GROUP B VITAMINS | 2013 |
|
RU2533276C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF GEL FOR TREATING METABOLIC INVOLVEMENTS OF OCULAR TISSUES | 2014 |
|
RU2575558C1 |
| EYE DROPS FOR TREATMENT OF DYSTROPHIC DISEASES AND TRAUMAS OF EYES | 2009 |
|
RU2414218C1 |
| OCULAR DROPS WITH REPARATIVE AND ANTI-GLAUCOMA ACTION | 2005 |
|
RU2295331C2 |
| EYE DROPS | 2012 |
|
RU2504372C1 |
| COMBINED OPHTHALMIC PREPARATION PRESENTED IN FORM OF EYE DROPS AND CONTAINING POLYHEXAMETHYLENE GUANIDINE AND TAURINE | 2012 |
|
RU2513997C1 |
| DOSAGE FORM BASED ON BUTYLAMINOHYDROXYPROPOXYPHENOXYMETHYL METHYLOXADIAZOLE | 2014 |
|
RU2585400C2 |
| EYE DROPS BASED ON PHARMACEUTICALLY TOLERABLE ADDITIVE SALTS OF ACID AND METHYL ETHYL ENCEPHABOL CONTAINING COMPOSITION OF VITAMINS B | 2013 |
|
RU2528912C1 |
